Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies
{{output}}
As ischemic heart disease (IHD) remains the leading cause of mortality worldwide, there is an urgent need for innovative therapies that go beyond symptom management. The irreversible damage to cardiac tissue following myocardial infarction (MI) and the limited... ...